China Capillary Blood Collection Devices Market

China Capillary Blood Collection Devices Market Insights Forecasts to 2035

• China Capillary Blood Collection Devices Market Size 2024: USD 145.8 Mn
• China Capillary Blood Collection Devices Market Size 2035:  USD 421.7 Mn
• China Capillary Blood Collection Devices Market CAGR 2024: 10.14%
• China Capillary Blood Collection Devices Market Segments: Product and Material

The China capillary blood collection device market is a growing rapidly and strategically one of the important segment of the medical devices industry, covering products such as lancets, microtainers, and automated collection systems. There is rising demand for point-of-care testing, growing healthcare infrastructure, and technical developments in minimally invasive collection and safety features are driving the market. It is distinguished by fierce rivalry between local and international producers, regulatory supervision, and expanding use in clinics, hospitals, and home testing. In addition, the market is evolving from basic devices to high-precision, automated, and patient-friendly solutions, blending China’s manufacturing strength with innovative technologies under a supportive healthcare framework.

China’s government reforms to expand decentralized care and tiered diagnosis–treatment systems have strengthened primary health care and community clinics, with over 90% of village clinics covered by basic medical insurance, boosting local services and creating demand for portable POCT devices that rely on capillary blood collection.

The China capillary blood collection device market is experiencing the strong growth and is driven by the rising demand for point-of-care testing, expanding decentralized healthcare, and the technological advancements such as AI-assisted diagnostics and automated sample handling. There are various opportunities which are emerging in innovative, patient-friendly devices, integrated testing platforms, and digital health solutions, supported by government initiatives promoting community clinics and precision healthcare, with rapid adoption fuelled by big data analytics, real-time monitoring, and the need for efficient, minimally invasive blood collection in both clinical and home settings.

Market Dynamics of the China Capillary Blood Collection Devices Market

The China capillary blood collection devices market is driven by a growing patient population, expanding decentralized healthcare, and the strong government support for primary care and point-of-care testing. The rise in the adoption of minimally invasive, safe, and the portable collection devices, coupled with technological innovations, increasing disposable incomes, and also the investments in smart healthcare solutions, is transforming the market from basic collection tools to advanced, patient-friendly, and automated devices, attracting both domestic and global manufacturers and establishing China as a key hub for innovative capillary blood collection solutions.

The China capillary blood collection devices market faces restraints such as fragmented regional regulations, strict quality and safety standards, limited trained healthcare personnel, and dependence on imported high-precision devices and components. Intellectual property protection, pricing pressures, and slow adoption in rural or lower-tier hospitals further challenge domestic innovation and profitability despite the market’s significant growth potential.

The future of China’s capillary blood collection device market looks very bright and promising, which is supported by healthcare reforms, rising demand for point-of-care testing, and the expansion of community and home-based care. Innovation in minimally invasive, safety-engineered, and automated devices, combined with digital health integration, remote monitoring, aging population needs, and growing chronic disease management, is enhancing testing efficiency, patient comfort, regulatory compliance, and access across China’s evolving diagnostics and preventive healthcare ecosystem.

Market Segmentation

The China Capillary Blood Collection Devices Market share is classified into Product and Material.

By Product

The China capillary blood collection devices is divided by product into lancets, micro-container tubes, micro-hematocrit tubes, warming devices, others. Among these, the lancets segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Due to their essential role in frequent glucose monitoring for diabetes, routine point-of-care testing (POCT), and increasing at-home self-testing, driving consistent high demand, with micro-container tubes also showing significant growth for handling small samples.

By Material

The China capillary blood collection devices market is divided by material into plastic, glass, stainless steel, ceramic, others. Among these, the plastic segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Due to its affordability, lightweight nature, durability, and excellent biocompatibility, making it ideal for safe, mass-produced, disposable devices.

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the China capillary blood collection devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in China Capillary Blood Collection Devices Market

• Becton Dickinson & Co
• Greiner Bio?One International GmbH
• Sarstedt AG & Co. KG
• Terumo Corp
• B. Braun Melsungen AG
• Guangzhou Improve Medical Instruments Co.
• Ltd, Abbott Laboratories
• Cardinal Health Inc.
• Others

Recent Developments in China Capillary Blood Collection Devices Market

In March 2025, Guangzhou Improve Medical Instruments Co., Ltd. continued expanding its portfolio of capillary blood sampling consumables, strengthening China’s domestic supply chain and supporting growing demand for capillary blood collection devices in diagnostics and point-of-care testing.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the China, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the China capillary blood collection devices market based on the below-mentioned segments:

China Capillary Blood Collection Devices Market, By Product

• Lancets
• Micro-Container Tubes
• Micro-Hematocrit Tubes
• Warming Devices
• Others.

China Capillary Blood Collection Devices Market, By Material

• Plastic
• Glass
• Stainless Steel
• Ceramic
• Others

FAQ

Q: What is the China capillary blood collection devices market size?

A: China capillary blood collection devices Market is expected to grow from USD 145.8 million in 2024 to USD 421.7 million by 2035, growing at a CAGR of 10.14% during the forecast period 2025-2035.

Q: How is the market segmented by product?

A: The market is segmented into lancets, micro-container tubes, micro-hematocrit tubes, warming devices, others.

Q: Who are the key players in the China capillary blood collection devices market?

A: Key companies include Becton Dickinson & Co, Greiner Bio?One International GmbH, Sarstedt AG & Co. KG, Terumo Corp, B. Braun Melsungen AG, Guangzhou Improve Medical Instruments Co., Ltd, Abbott Laboratories, Cardinal Health Inc., Others.

Q: Who are the target audiences for this market report?

A: The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).